Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

The Combination of Nilotinib + Pegylated IFN Alpha 2a Provides Somewhat Higher Cumulative Incidence Rates of MR4.5 at M36 Versus Nilotinib Alone in Newly Diagnosed CP CML Patients. Updated Results of the Petals Phase III National Study.

Blood (2019) 134 (Supplement_1): 494.

https://doi.org/10.1182/blood-2019-123674

Published: 2019

Journal Articles

Pre-Conditioning Serum Leptin Levels Predict Early Relapse Rates of High Risk AML after Allogeneic Stem Cell Transplantation

Mark-Alexander Schwarzbich, MD, Hao Dai, Lambros Kordelas, MD, Dietrich W. Beelen, Aleksandar Radujkovic, MD, Carsten Müller-Tidow, MD, Peter Dreger, MD, Thomas Luft, MD PhD

Blood (2018) 132 (Supplement 1): 3419.

https://doi.org/10.1182/blood-2018-99-112807

Published: 2018

Journal Articles

Liver Biopsy in Patients with Chronic Lymphocytic Leukemia: Indications and Pathological Findings

Paul J. Hampel, MD, Rebecca L King, MD, Curtis A. Hanson, MD, Douglas Simonetto, MD, Kari G. Chaffee, MS, Timothy G. Call, MD, Wei Ding, MD PhD, Saad S Kenderian, MD, Susan L. Slager, PhD, Neil E. Kay, MD, Tait D. Shanafelt, MD, Sameer A. Parikh, MD

Blood (2016) 128 (22): 5592.

https://doi.org/10.1182/blood.V128.22.5592.5592

Published: 2016

Journal Articles

Phenotypic and Transcriptional Characterization of Non-Hodgkin Lymphomas from Malawi Defines Targetable Disease Subsets

Elizabeth A. Morgan, MD, M. Patrick Sweeney, Tamiwe Tomoka, MD, Nadja Kopp, M.S., Robert A Redd, MS, Christopher Daniel Carey, MD,, Leo Masamba, MD, Steve Kamiza, MD, Geraldine S Pinkus, MD, Donna S. Neuberg, Sc.D., Scott J. Rodig, MD, PhD, Danny A. Milner, Jr., MD, M.Sc., David M. Weinstock, MD

Blood (2015) 126 (23): 2655.

https://doi.org/10.1182/blood.V126.23.2655.2655

Published: 2015

Journal Articles

Hemodynamic, Functional and Structural Markers of Vascular Involvement in Primary Systemic Light Chain (AL) Amyloidosis

Kimon Stamatelopoulos, Marita Lyka, Christos Papamichail, Maria Roussou, Maria Gavriatopoulou, Constantinos Pamboucas, Evangelos Terpos, Meletios A. Dimopoulos, Efstathios Kastritis, MD

Blood (2014) 124 (21): 2029.

https://doi.org/10.1182/blood.V124.21.2029.2029

Published: 2014

Journal Articles

A Phase II Trial Of Bortezomib-Rituximab Followed By Autologous Stem Cell Harvest (SCH) and Cladribine-Cyclophosphamide-Rituximab (2CdA-Cy-Rit) Consolidation As Primary Therapy Of Waldenström's Macroglobulinemia (WM)

Sheeba K. Thomas, M.D., Tamara M Haygood, M.D., Muzaffar H. Qazilbash, MD, A. Georgina Melendez, M.D., Roxana Galvis, Kay B Delasalle, B.S., Lei Feng, M.S., Tiffany A. Richards, M.S., Felipe Samaniego, M.D., M.P.H, Luhua Wang, M.D., Jatin J. Shah, M.D., Robert Z. Orlowski, M.D., Ph.D., Donna M. Weber, M.D.

Blood (2013) 122 (21): 4396.

https://doi.org/10.1182/blood.V122.21.4396.4396

Published: 2013

Journal Articles

Neuroendocrine Regulation Of The IL-27-Dependent Immune Response In Macrophages

Markus Bosmann, MD, Julian Roewe, Dennis Riehl, Matthias Theobald, MD, PhD, Peter A. Ward, MD

Blood (2013) 122 (21): 3460.

https://doi.org/10.1182/blood.V122.21.3460.3460

Published: 2013

Journal Articles

Other Cancers in Patients with Chronic Lymphocytic Leukemia Requiring Therapy: Association with Prognostic Factors and Impact On Survival

Lorenzo Falchi, MD, Michael J. Keating, MD, Susan Lerner, MS, Xuemei Wang, MS, Sara S. Strom, PhD, William G. Wierda, MD, Alessandra Ferrajoli, M.D.

Blood (2012) 120 (21): 3896.

https://doi.org/10.1182/blood.V120.21.3896.3896

Published: 2012

Journal Articles

Effects of NVP-BSK805, a Novel JAK2 Inhibitor, on BCR-ABL and JAK2 V617F Positive Cell Lines

Frauke Ringel, PhD, Jaspal S Kaeda, PhD, FRCPath, Michaela Schwarz, MD, Peggy Grille, Bernd Dörken, Philipp D. le Coutre, MD

Blood (2011) 118 (21): 5002.

https://doi.org/10.1182/blood.V118.21.5002.5002

Published: 2011

Journal Articles

C-Myb Regulates Mir-101 Expression During the Early Stages of Erythropoiesis

Giselle Brito, Ningkun Li, Susan E. Shetzline, PhD

Blood (2010) 116 (21): 3876.

https://doi.org/10.1182/blood.V116.21.3876.3876

Published: 2010

Journal Articles

Treatment of Primary Granulocytic Sarcoma of the Uterine Cervix: Reports of Three Cases

Zhang Jie, Sr, physician, Meng Xiao Jian, physician, Ye Xiu Jin, Jing-Song He, He Huang, MD, PhD

Blood (2010) 116 (21): 4346.

https://doi.org/10.1182/blood.V116.21.4346.4346

Published: 2010

Journal Articles

Detection of LMO2 in Normal Human Tissues and Haematopoietic and Non-Haematopoietic Tumours by a Newly Developed Rabbit Monoclonal Antibody.

Claudio Agostinelli, Jennifer C Paterson, Rajeev Gupta, Simona Righi, Federica Sandri, Pier Paolo Piccaluga, Francesco Bacci, Elena Sabattini, Stefano A. Pileri, MD, Teresa Marafioti, MD

Blood (2009) 114 (22): 2942.

https://doi.org/10.1182/blood.V114.22.2942.2942

Published: 2009

Journal Articles

Defibrotide: Seamless Phase I/II Dose Escalation Trial (ICSRI DF#1) to Stratify the Polypharmacology of a Cell Modulator to the Polypharmacology of Multi Organ Failure: Part I, Clinical Design, and Therapeutic Results

Arsinur Oral, MD

Blood (2008) 112 (11): 4316.

https://doi.org/10.1182/blood.V112.11.4316.4316

Published: 2008

Journal Articles

Serial Plasma Concentrations of Adipocytokines during Chemotherapy in Children with Acute Lymphoblastic Leukemia

Maria M Moschovi, Georgios G Trimis, Maria M Vounatsou, Katerina K Katsibardi, Alexandra A Margeli, Andreas A Damianos, George G Chrousos, Fotini F Tzortzatou-Stathopoulou, Ioannis I Papassotiriou

Blood (2008) 112 (11): 3937.

https://doi.org/10.1182/blood.V112.11.3937.3937

Published: 2008

Journal Articles

High-Dose Chemotherapy in Small Cell Neuroendocrine Carcinoma: Favorable Long-Term Outcome for Extrapulmonary Primary Localization.

Antonia M.S. Mueller, MD, Alex Kuehnemund, MD, Monika Engelhardt, MD

Blood (2006) 108 (11): 3075.

https://doi.org/10.1182/blood.V108.11.3075.3075

Published: 2006

Journal Articles

Favorable Outcomes with CHOP Therapy in Plasmablastic Lymphoma in HIV Positive Patients.

Masumeh Rafati Javidan, MD, Alpesh J. Amin, MD, Gunwant Guron, MD

Blood (2005) 106 (11): 4696.

https://doi.org/10.1182/blood.V106.11.4696.4696

Published: 2005

Journal Articles

HIV-1 Proviral Integration Is Blocked by Agonists to the VpPAC2 Neuroendocrine Receptor.

Donald R. Branch, PhD, Payman Baradar Bokaei, MSc, Darinka Sakac, MSc, Xue-Zhong Ma, MD

Blood (2005) 106 (11): 1427.

https://doi.org/10.1182/blood.V106.11.1427.1427

Published: 2005

Journal Articles

Insulin-Like Growth Factor I Is a Positive Regulator of Thymic Function.

Yu-Waye Chu, M.D., Shoshana Yakar, Ph.D., Derek LeRoith, Ph.D., Ronald Gress, M.D.

Blood (2004) 104 (11): 732.

https://doi.org/10.1182/blood.V104.11.732.732

Published: 2004

NARROW

The Combination of Nilotinib + Pegylated IFN Alpha 2a Provides Somewhat Higher Cumulative Incidence Rates of MR4.5 at M36 Versus Nilotinib Alone in Newly Diagnosed CP CML Patients. Updated Results of the Petals Phase III National Study.

Pre-Conditioning Serum Leptin Levels Predict Early Relapse Rates of High Risk AML after Allogeneic Stem Cell Transplantation

Liver Biopsy in Patients with Chronic Lymphocytic Leukemia: Indications and Pathological Findings

Phenotypic and Transcriptional Characterization of Non-Hodgkin Lymphomas from Malawi Defines Targetable Disease Subsets

Hemodynamic, Functional and Structural Markers of Vascular Involvement in Primary Systemic Light Chain (AL) Amyloidosis

A Phase II Trial Of Bortezomib-Rituximab Followed By Autologous Stem Cell Harvest (SCH) and Cladribine-Cyclophosphamide-Rituximab (2CdA-Cy-Rit) Consolidation As Primary Therapy Of Waldenström's Macroglobulinemia (WM)

Neuroendocrine Regulation Of The IL-27-Dependent Immune Response In Macrophages

Other Cancers in Patients with Chronic Lymphocytic Leukemia Requiring Therapy: Association with Prognostic Factors and Impact On Survival

Effects of NVP-BSK805, a Novel JAK2 Inhibitor, on BCR-ABL and JAK2 V617F Positive Cell Lines

C-Myb Regulates Mir-101 Expression During the Early Stages of Erythropoiesis

Treatment of Primary Granulocytic Sarcoma of the Uterine Cervix: Reports of Three Cases

Detection of LMO2 in Normal Human Tissues and Haematopoietic and Non-Haematopoietic Tumours by a Newly Developed Rabbit Monoclonal Antibody.

Defibrotide: Seamless Phase I/II Dose Escalation Trial (ICSRI DF#1) to Stratify the Polypharmacology of a Cell Modulator to the Polypharmacology of Multi Organ Failure: Part I, Clinical Design, and Therapeutic Results

Serial Plasma Concentrations of Adipocytokines during Chemotherapy in Children with Acute Lymphoblastic Leukemia

High-Dose Chemotherapy in Small Cell Neuroendocrine Carcinoma: Favorable Long-Term Outcome for Extrapulmonary Primary Localization.

Favorable Outcomes with CHOP Therapy in Plasmablastic Lymphoma in HIV Positive Patients.

HIV-1 Proviral Integration Is Blocked by Agonists to the VpPAC2 Neuroendocrine Receptor.

Insulin-Like Growth Factor I Is a Positive Regulator of Thymic Function.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only